S Heinemann

Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial

Jürgen Behr, Antje Prasse, Michael Kreuter et al. · The Lancet Respiratory Medicine · 2021 · 516 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +9

Alveolar Fibrin Formation Caused by Enhanced Procoagulant and Depressed Fibrinolytic Capacities in Severe Pneumonia: Comparison with the Acute Respiratory Distress Syndrome

Andreas Günther, PARVIN MOSAVI, S Heinemann et al. · American Journal of Respiratory and Critical Care Medicine · 2000 · 299 citations

Medicine, Infectious Diseases, Hemostasis +14

The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis

Andreas Günther, Ekaterina Krauss, Silke Tello et al. · Respiratory Research · 2018 · 259 citations · Full text

Medicine, Internal Medicine, Clinical Epidemiology +9

Serum Levels of Vascular Endothelial Growth Factor Are Elevated in Patients with Obstructive Sleep Apnea and Severe Nighttime Hypoxia

Richard Schulz, Christoph Hummel, S Heinemann et al. · American Journal of Respiratory and Critical Care Medicine · 2002 · 225 citations

Medicine, Physiology, Sleep Disorders In Older Adults +14

Enhanced Tissue Factor Pathway Activity and Fibrin Turnover in the Alveolar Compartment of Patients with Interstitial Lung Disease

Andreas Günther, PARVIN MOSAVI, Clemens Ruppert et al. · Thrombosis and Haemostasis · 2000 · 79 citations

Medicine, Pathobiology, Hemostasis +12